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Bacterial meningitis is a rapidly progressive infection
whose prognosis depends on prompt initiation of adequate
antimicrobial therapy [1, 2]. In case of suspicion of bac-
terial meningitis blood cultures are needed. Since diag-
nosis of meningitis depends on signs of inflammation in
the cerebrospinal fluid, early lumbar puncture is crucial
[3]. However, if there is suspicion of increased intracra-
nial pressure, brain computed tomography must be per-
formed to recognize those patients in whom lumbar
puncture is contraindicated [2]. In these cases antibiotic
therapy should be initiated prior to CT in order not to
loose time until definite diagnosis, since delay in initial
administration of antibiotic therapy deteriorates prognosis
[3, 4]. In view of this emergency situation antibiotics are
frequently given even in patients with suspected viral
meningitis. In general this does not harm the individual
patient with viral disease. However, it may have an im-
pact on the local frequency of antibiotic resistance, which
depends significantly on the amount of antibiotic con-
sumption [5]. Thus, it is not only important to recognize
patients who immediately need antibiotics but also those
who do not need antimicrobial therapy at all.
The clinical differentiation of bacterial from viral
meningitis is difficult and has been studied mainly in
children [6]. The classical signs and symptoms of men-
ingitis such as fever, headache, photophobia, nausea,
vomiting, and neck and back pain do not allow discrim-
ination between the two origins. Therefore the charac-
teristics of cerebrospinal fluid (CSF) have been used to
differentiate between bacterial and viral meningitis [7, 8].
In most studies CSF lactate (>4 mmol/l) is a better pre-
dictor of bacterial origin than glucose ratio (less than 0.4),
the number of white blood cells in CFS (>1000106/l),
and the percentage of polymorphonuclear leukocytes in
CSF (>50%) [9, 10, 11].
Since no single CSF or blood parameter has been able
to discriminate between bacterial and viral meningitis, a
model for the differential diagnosis has been introduced
by Spanos et al. [7] and validated in more recent series
[12, 13, 14]. Four independent variables are used here to
calculate the probability of bacterial (pABM, i.e., odds of
bacterial relative to viral meningitis) vs. viral meningitis,
namely CSF protein level, total CSF polymorphonuclear
count, blood glucose level, and leukocyte count. Setting
the cutoff point of pABM is set at 0.1 has been shown to
be optimal for the discrimination (Table 1). This is true
both for children [13] and for adults [12].
Despite this validated, sophisticated model, it would be
an advantage to have clinical criteria to distinguish bac-
terial from viral meningitis for the following reasons: (a)
CSF characteristics are sometimes misleading, especially
regarding leukocyte counts and percentage of polymor-
phonuclear leukocytes [15], (b) in case of suspicion of
Table 1 Performance of the model for a cutoff point of the prob-
ability of bacterial meningitis (pABM) of 0.1: pABM=[1/(1+eL)],
where L=32.1310-4 CSF PMN count (106/l), + 2.365 CSF
protein (g/l), +0.6143 x blood glucose (mmol/l), +0.2086 blood
leukocyte count (109/l)11
Sensitivity Specificity PPV NPV
Jaeger et al. [13] 97.9% 94.4% 95.9% 97.1%
Hoen et al. [12] 97% 93% 85% 99%
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increased intracranial pressure antibiotics must be started
before CSF puncture, and (c) dexamethasone treatment
should be given before starting antibiotics, thus often
even before lumbar puncture.
As mentioned above, the initial signs of meningitis are
similar regardless of origin. However, bacterial but not
viral meningitis rapidly leads to cortical necrosis caused
by decreased cerebral blood flow due to oxidative damage
and inadequate vasoconstriction. In addition, hippocampal
apoptosis occurs via bacterial products directly and
through granulocyte products [16, 17]. Thus the bacterial
origin of meningitis may be recognized as soon as the first
neurological damage clinically appears. Such clinical
signs are altered mental status, seizures, and focal neuro-
logical deficits. Two large studies by Durand et al. [18]
and Aronin et al. [4] found, respectively, that 78% and
83% of the patients with bacterial meningitis had an al-
tered mental status, and that 23% and 13% had seizures. In
the study by Durand et al. [18] 28% had focal neurological
deficits. In view of these frequent signs of bacterial origin
in patients with meningitis, Brivet et al. [19] analyzed the
clinical value of signs of severity to differentiate bacterial
from viral meningitis in a retrospective cohort study in-
volving 140 adults with different causes of meningitis.
They analyzed the role of the initial clinical presentation
and the relative diagnositic value of CSF parameters. This
study focused especially on signs of severity at referral,
including an impaired mental status (Glasgow Coma Scale
score less than 14), seizure before or at presentation, focal
neurological deficit, and shock. Clinical features were
similar in bacterial and viral meningitis, except for head-
ache (63% vs. 94%, p less than 0.01) and signs of severity
(99% vs. 7.4%, p less than 0.01). The presence of at least
one sign of severity was the only clinical, and CSF neu-
trophil counts higher than 1000106/l the only laboratory
predictor of bacterial origin. In the study by Brivet et al.
[19] the hospital mortality decreased from 46% to 24%
between the first and the second halves of the study pe-
riod. Because the data were analyzed only for the whole
period, it is not clear whether signs of severity were pre-
dictive in each period separately. One could argue that
only cases with a long delay before treatment could be
clinically recognized as meningitis of bacterial origin.
However, since patient characteristics did not differ be-
tween the two groups, the delay before antibiotic treatment
was probably similar in both groups. According to the
receiver operating characteristic curve, the presence of at
least one sign of severity at presentation had an excellent
accuracy in detecting the bacterial origin of meningitis.
With a sensitivity of 0.989, specificity of 0.981, positive
predictive value of 0.989, and negative predictive value of
0.981, one would be tempted to withhold antibiotics from
patients with meningitis not presenting any sign of
severity. The authors were right not to draw this conclu-
sion. As long as their data are not prospectively confirmed
in patients with early presentation and a better clinical
outcome (less than 20% mortality), most patients with
meningitis should still receive antibiotics in the emergency
room. In the meantime it is still important to recognize
patients in whom antibiotics can be stopped after ex-
cluding bacterial origin of meningitis. Rapid and reliable
culture techniques for bacteria and polymerase chain re-
action techniques for the most important viral agents are
important tools for this purpose. In the future the sensitive
assay for procalcitonin may allow differentiating patients
with bacterial from those with viral meningitis [20].
In conclusion, for the time being, the data of Brivet et
al. [19] allow us to recognize patients who rapidly need
antibiotics and supportive care in an intensive care unit.
However, before antibiotics can be withhold in every
patient without signs of severity, this study must be
confirmed in patients with very early presentation of
bacterial meningitis who take most advantage of early
antibiotic therapy.
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